Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lyra RSV+hMPV Assay

K-Number: K230349 · 2023-03-10

Decision Date2023-03-10
Product CodeOEM
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Lyra RSV+hMPV Assay is the device name listed in this FDA 510(k) record. The listed applicant is Quidel Corporation. It received FDA 510(k) clearance on 2023-03-10 under 510(k) number K230349. The device is classified under product code OEM. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lyra RSV+hMPV Assay?

Lyra RSV+hMPV Assay is a medical device that received FDA 510(k) clearance on 2023-03-10. The listed applicant is Quidel Corporation. The 510(k) number is K230349.

When did Lyra RSV+hMPV Assay receive FDA 510(k) clearance?

Lyra RSV+hMPV Assay received FDA 510(k) clearance on 2023-03-10, under 510(k) number K230349.

Who is the listed applicant for Lyra RSV+hMPV Assay?

The FDA 510(k) record lists Quidel Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lyra RSV+hMPV Assay?

The FDA product code for Lyra RSV+hMPV Assay is OEM.

Other records listing Quidel Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 22 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.